Analysts Are Upgrading Amprius Technologies, Inc. (NYSE:AMPX) After Its Latest Results

In This Article:

A week ago, Amprius Technologies, Inc. (NYSE:AMPX) came out with a strong set of quarterly numbers that could potentially lead to a re-rate of the stock. Results clearly exceeded expectations, with a substantial revenue beat leading to smaller losses in what looks like a definite win for investors. Revenues were US$11m and the statutory loss per share was US$0.08, smaller than the analysts had forecast. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

earnings-and-revenue-growth
NYSE:AMPX Earnings and Revenue Growth May 11th 2025

Taking into account the latest results, the most recent consensus for Amprius Technologies from seven analysts is for revenues of US$61.7m in 2025. If met, it would imply a sizeable 86% increase on its revenue over the past 12 months. The loss per share is expected to greatly reduce in the near future, narrowing 21% to US$0.30. Yet prior to the latest earnings, the analysts had been forecasting revenues of US$56.2m and losses of US$0.36 per share in 2025. There's been a pretty noticeable increase in sentiment, with the analysts upgrading revenues and making a favorable reduction in loss per share in particular.

View our latest analysis for Amprius Technologies

It will come as no surprise to learn thatthe analysts have increased their price target for Amprius Technologies 13% to US$9.50on the back of these upgrades. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. Currently, the most bullish analyst values Amprius Technologies at US$15.00 per share, while the most bearish prices it at US$6.00. This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business.

Of course, another way to look at these forecasts is to place them into context against the industry itself. It's clear from the latest estimates that Amprius Technologies' rate of growth is expected to accelerate meaningfully, with the forecast 129% annualised revenue growth to the end of 2025 noticeably faster than its historical growth of 75% p.a. over the past three years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 8.1% per year. Factoring in the forecast acceleration in revenue, it's pretty clear that Amprius Technologies is expected to grow much faster than its industry.